<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Major <z:hpo ids='HP_0000716'>depression</z:hpo> afflicts 20-25% of patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Of these, about a third do not improve with antidepressant therapy and may be suitable candidates for electronconvulsive treatment (ECT) </plain></SENT>
<SENT sid="2" pm="."><plain>However, the use of ECT is <z:hpo ids='HP_0000726'>dementia</z:hpo> patients is concerning due to possible adverse effects on memory and cognition </plain></SENT>
<SENT sid="3" pm="."><plain>Outcome studies of ECT in patients with primary <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0000716'>depression</z:hpo> are very rare </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: To determine the effectiveness and complications of ECT treatment for <z:hpo ids='HP_0000716'>depression</z:hpo> in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>METHOD: A chart review was conducted of <z:hpo ids='HP_0000001'>all</z:hpo> 31 patients wit ha discharge diagnosis of '<z:hpo ids='HP_0000726'>Dementia</z:hpo> with <z:hpo ids='HP_0000716'>depression</z:hpo>' treated with ECT at the Johns Hopkins Hospital, over a five-year period </plain></SENT>
<SENT sid="6" pm="."><plain>Admission and discharge ratings were made on the Mini-Mental State Examination (MMSE) and the Montgomery-Asberg <z:hpo ids='HP_0000716'>Depression</z:hpo> Rating Scale (MADRS) as part of the clinical routine </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients suffered from <z:hpo ids='HP_0000726'>dementia</z:hpo>: 55% had vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 13% <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and 32% degenerative <z:hpo ids='HP_0000726'>dementia</z:hpo> of uncertain etiology </plain></SENT>
<SENT sid="8" pm="."><plain>The admission MADRS mean score was 27.5 (SD 8.1) and the MMSE mean score was 18.8 (SD 5 </plain></SENT>
<SENT sid="9" pm="."><plain>5) </plain></SENT>
<SENT sid="10" pm="."><plain>The patients received between 1 and 23 ECT treatments (mean 9, SD 5.7) </plain></SENT>
<SENT sid="11" pm="."><plain>At discharge, there was a statistically significant mean decline on the MADRS of 12.28 points (p&lt;0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>Forty percent had scores less than 10 (<z:mpath ids='MPATH_458'>normal</z:mpath>) on the MADRS </plain></SENT>
<SENT sid="13" pm="."><plain>While 49% of patients developed <z:e sem="disease" ids="C0011206" disease_type="Mental or Behavioral Dysfunction" abbrv="">delirium</z:e>, by discharge there was also a significant mean increase (improvement) in MMSE of 1.62 points (p&lt;0.02) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: ECT is an effective treatment for <z:hpo ids='HP_0000716'>depression</z:hpo> in <z:hpo ids='HP_0000726'>dementia</z:hpo>, leading to improvements in both mood and cognition </plain></SENT>
<SENT sid="15" pm="."><plain>Multiple ECT treatments may be necessary before a significant improvement in mode is achieved </plain></SENT>
</text></document>